About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Screening for Malnutrition in Obese Patients | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT06626360

Screening for Malnutrition in Obese Patients

More than half of the Dutch population is overweight or obese, which is associated with an increased risk of COVID-19 and worse outcomes during a COVID-19 infection. In addition, malnutrition and loss...

Lead sponsor: HAN University of Applied Sciences•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Marian A de van der Schueren, PhD

CONTACT

+31-024-353-0500 marian.devanderschueren@han.nl

Sponsors

Lead Sponsor

HAN University of Applied Sciences

Collaborators

Amsterdam University of Applied Sciences
National Institute for Public Health and the Environment (RIVM)
Erasmus Medical Center
Wageningen University and Research
Gelderse Vallei Hospital
Amsterdam UMC, location VUmc
Amsterdam UMC, location AMC

Overweight and malnutrition are both common and have a significant societal impact as well as a negative effect on healthcare. They can also coexist, and may potentially reinforce each other. How the combination of both influences the course of COVID-19 and other diseases is still largely unknown. There is no simple set of parameters yet available to screen for the simultaneous occurrence of overweight and malnutrition. This project has the following objectives: * To evaluate the nutritional status (malnutrition, overweight, and the combination of both) and the (dietary) treatment of patients with COVID-19 in primary care (WP1). * To assess the influence of various parameters of malnutrition and overweight and their effects on the outcomes of COVID-19 and cancer based on literature and data from existing Dutch cohorts (WP2 and WP3). Based on this, to develop a screening tool for malnutrition in overweight; (WP4). \- Dissemination of the results (WP5).

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 18 years or older
•Overweight (BMI of 25 kg/m² or higher)

Exclusion Criteria

•Physically or mentally unable to participate.
•Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician.
•Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help.
•Patient resides in a nursing or care home.

Related studies

Mother Screening for Relapse Using Mid-upper Arm Circumference Among Children Recovered From Severe Acute Malnutrition (Full Scale Trial)

NCT06599580 · Malnutrition, Child, Malnutrition, Infant, and more

RECRUITINGPhase 2

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)

NCT06599918 · Fatty Liver, Obesity, and more

Not Yet RecruitingPhase 4

RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.

NCT07301437 · Overweight and Obese Adults

Not Yet RecruitingNA

Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA

NCT07433946 · Ulcerative Colitis (Disorder), Crohn Disease, and more

Psychophysiological and Cognitive Responses to Low-Volume High-Intensity Interval Exercise in Overweight-to-Obese Adults

NCT07276308 · Overweight and/or Obesity, Overweight and Obese Adults

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 8, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment2,000

Start dateOct 2024

Last updatedNov 8, 2024

Condition

Overweight and Obese Adults Malnutrition or Risk of Malnutrition

Locations shown

OLVG

Amsterdam

Ziekenhuis Gelderse Vallei

Ede

ErasmusMC

Rotterdam

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions